ADENOSINE HIKMA 6 mg/2 ml, solution for injection 10 ampoules of 2 ml
Active ingredients: Adenosine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection10 ampoules of 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADENOSINE HIKMA 6 mg/2 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jan 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67537114CIP75508656CIP133400955086567Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADÉNOSINEsolution | 6 mg · une ampoule de 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.